Cipla Q4 net profit drops 55% YoY to ₹555 crore, revenue falls 3%; ₹13/share dividend recommended

In the corresponding quarter of the preceding fiscal year, it had logged a profit of ₹1,221.84 crore in the year-ago period, according to a regulatory filing.

During the quarter and year ended 31st March 2026, the group recorded an impairment of ₹42.02 crores in the financial results in respect of associates, on account of a change in certain business conditions and market dynamics, Cipla said.

Its revenue from operations dropped 2.8% YoY to ₹6,541.2 crore during the quarter under review, compared to ₹6,729.69 crore in the January-March quarter of the 2024-25 fiscal year (Q4 FY25).

At an operational level, its EBITDA (earnings before interest, tax, depreciation and amortisation), also known as operating profit, stood at ₹955 crore in Q4 FY26, reflecting a 38% YoY fall from ₹1,538 crore in the year-ago period.

The pharma major’s EBITDA margin contracted to 14.6% for the reporting quarter, from 22.80% in the March FY25 quarter.

Final dividend recommended

Cipla’s board of directors also recommended a final dividend of ₹13 per equity share, with a face value of ₹2 each for the financial year ending 31st March, 2026.

“The dividend is subject to the approval of the shareholders at the ensuing annual general meeting of the Company,” the firm added.

Furthermore, it fixed Friday, June 5, 2026, as the record date for the same.

Appointments

The company’s board of directors also approved the appointment of Sushrut Kulkarni as the President & Global Chief, Integrated Product Development (IPD), member of the Management Council, and Senior Management Personnel (SMP) of Cipla, with effect from May 18, 2026.

Furthermore, it approved the appointment of Joshi Apte & Associates, Cost Accountants, as cost auditors of the company for the 2026-27 fiscal year (FY27).

Shares of the pharmaceutical company were trading 2.59% higher at ₹1,325.80 per unit on the National Stock Exchange (NSE), following the result announcement.

Cipla has a total market capitalisation of ₹1.07 lakh crore as of May 13, 2026, according to data on the NSE.